Unknown

Dataset Information

0

GPER Agonist G-1 Disrupts Tubulin Dynamics and Potentiates Temozolomide to Impair Glioblastoma Cell Proliferation.


ABSTRACT: Glioblastoma (GBM) is the most common brain tumor in adults, which is very aggressive, with a very poor prognosis that affects men twice as much as women, suggesting that female hormones (estrogen) play a protective role. With an in silico approach, we highlighted that the expression of the membrane G-protein-coupled estrogen receptor (GPER) had an impact on GBM female patient survival. In this context, we explored for the first time the role of the GPER agonist G-1 on GBM cell proliferation. Our results suggested that G-1 exposure had a cytostatic effect, leading to reversible G2/M arrest, due to tubulin polymerization blockade during mitosis. However, the observed effect was independent of GPER. Interestingly, G-1 potentiated the efficacy of temozolomide, the current standard chemotherapy treatment, since the combination of both treatments led to prolonged mitotic arrest, even in a temozolomide less-sensitive cell line. In conclusion, our results suggested that G-1, in combination with standard chemotherapy, might be a promising way to limit the progression and aggressiveness of GBM.

SUBMITTER: Hirtz A 

PROVIDER: S-EPMC8699794 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC452570 | biostudies-literature
| S-EPMC6131782 | biostudies-literature
| S-EPMC4724489 | biostudies-literature
2022-04-27 | GSE191126 | GEO
| S-EPMC4570246 | biostudies-literature
| S-EPMC3716364 | biostudies-literature
| S-EPMC6627323 | biostudies-literature
| S-EPMC5940876 | biostudies-literature
| S-EPMC5767971 | biostudies-literature
| S-EPMC7252967 | biostudies-literature